All results
5 results for incmga00012 combination other therapies patients advanced solid tumors
-
Clinical Trials
This is a First-in-Human Phase IA/IB/II open label dose escalation study of intravenous (IV) administration of ONC-392, a humanized anti-CTLA4 IgG1 monoclonal…
-
Clinical Trials
This phase II trial tests whether ZEN003694 (ZEN-3694) in combination with talazoparib works to shrink tumors in patients with solid tumors that are unlikely…
-
Clinical Trials
This phase III trial compares the usual treatment (treatment with ipilimumab and nivolumab followed by nivolumab alone) to treatment with ipilimumab and…
-
Specialties
At UF, we are dedicated to providing personalized, compassionate and evidence-based care to patients with cancer and blood disorders. Hematology and oncology…
-
News, Stories & Blog
UF Health pediatric oncologist Elias Sayour, M.D., Ph.D., has received a $2.5 million grant from the pediatric cancer foundation CureSearch for Children’s…